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Abstract: Pyrroloquinoline quinone (PQQ) was produced by fermentation of the 
Methylovorus sp. MP688 strain and purified by ion-exchange chromatography, crystallization 
and recrystallization. The yield of PQQ reached approximately 125 mg/L and highly pure 
PQQ was obtained. To determine the optimum dose of PQQ for radioprotection, three doses 
(2 mg/kg, 4 mg/kg, 8 mg/kg) of PQQ were orally administrated to the experimental animals 
subjected to a lethal dose of 8.0 Gy in survival test. Survival of mice in the irradiation + PQQ 
(4 mg/kg) group was found to be significantly higher in comparison with the irradiation 
and irradiation + nilestriol (10 mg/kg) groups. The numbers of hematocytes and bone 
marrow cells were measured for 21 days after sublethal 4 Gy gamma-ray irradiation with 
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per os of 4 mg/kg of PQQ. The recovery of white blood cells, reticulocytes and bone 
marrow cells in the irradiation + PQQ group was faster than that in the irradiation group. 
Furthermore, the recovery of bone marrow cell in the irradiation + PQQ group was 
superior to that in irradiation + nilestriol group. Our results clearly indicate favourable 
effects on survival under higher lethal radiation doses and the ability of pyrroloquinoline 
quinine to enhance haemopoietic recovery after sublethal radiation exposure. 
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1. Introduction 
Pyrroloquinoline quinone (PQQ), also known as methoxatin, was identified as a cofactor   
of bacterial dehydorgenases, including methanol dehydrogenase, glucose dehydrogenase, alcohol 
dehydrogenase, aldehyde dehydrogenase, etc. [1–4]. PQQ has multiple physiological functions [5], 
such as participating in the electron transport [6], enhancing the adaptability of microbes against 
extreme environments [7], improving the growth of plants [8], and stimulating the production of nerve 
growth factor [9], which presents wide application prospect in food industry, pharmaceuticals and 
agriculture. At present, the organic chemical synthesis of PQQ requires many steps taking a very long 
time and requires difficult steps for the removal of isomers and various other byproducts [10], whereas 
bacterial production of PQQ is considered to be economical and environmentally friendly. PQQ has 
been found to be present in various gram-negative bacteria [11]. Methylotrophs were most outstanding 
for the production of PQQ. Methylovorus sp. strain MP688 (CGMCC No.4096) was collected from 
soil by our lab as a PQQ producer [12]. The complete genome sequence of MP688 has been sequenced 
and genes involved in PQQ biosynthesis have been isolated and identified [13]. 
Recently, it is reported that PQQ could scavenge reactive oxygen species (ROS) [14] and protect 
AGS cells from oxidative stress-induced damage [15]. PQQ can also effectively improve the activities 
of free radicals scavenging enzymes and decrease the levels of free radicals [16]. Furthermore, PQQ 
could prevent oxidative stress-induced neuronal death [17]. These results suggest that PQQ acts as 
radioprotectant by reducing oxidative damage. In this study, we produced PQQ by fermentation of the 
methylovorus sp. MP688 strain and investigated the possible acute radioprotective effect of PQQ in 
vivo on survival and haematopoietic system in total body irradiated mice. The radioprotective   
effect of PQQ was also compared with that of nilestriol, which is a representative clinically used 
estrogenic radioprotector. 
2. Results and Discussion 
2.1. PQQ Fermentation, Purification and Detection 
The Methylovorus sp. MP688 batch fermentation was performed in a 3-L fermentor using MM 
medium. A time-course study of the PQQ concentration in the supernatant revealed a gradual 
accumulation of PQQ. The yield of PQQ reached for 125 mg/L after 6 days of fermentation. Ameyama et al. 
showed that some methylotrophs were most favorable for study of PQQ production and that more than Int. J. Mol. Sci. 2011, 12 8915 
 
 
10 μg/mL PQQ was produced in broth after 2 days of incubation [18], and van Kleef and Duine 
reported that a large number of bacteria, including methylotrophs, extracellularly produced PQQ in 
microgram amounts per mL of broth [19]. For Hyphomicrobium sp. strain TK 0441 at suitable medium, 
the production of PQQ reached approximately 1 mg/mL at 10 days of cultivation [20]. 
The best conditions for extractions of PQQ from crude medium supertenant were investigated with 
various methods. PQQ was efficiently extracted by anion-exchange chromatography, rotary evaporation, 
crystallization and recrystallization. 
2.2. Survival of Mice After Irradiation 
For confirmation of the optimum dose of PQQ for radioprotection, three doses (2 mg/kg, 4 mg/kg,  
8 mg/kg) of PQQ were orally administrated to the experimental animals subjected to a lethal dose of 
8.0 Gy irradiation in survival test. As shown in Figure 1, survival of the mice treated with   
irradiation + nilestriol (10 mg/kg) or irradiation + PQQ (2 mg/kg, 4 mg/kg) was found to be 
significantly higher in comparison with that of the mice treated with irradiation. The most significant 
differences of survival between the irradiation + PQQ (4 mg/kg) group and the irradiation group 
animals were also observed. Furthermore, survival of the drug group (4 mg/kg PQQ) is also higher 
than that of positive control group (10 mg/kg nilestriol). Therefore, 4 mg/kg dosage was selected to 
compare the radioprotective effects of PQQ on hematopoietic function in this study. 
Figure 1. Kaplan–Meier estimate of 30-day survival of 8 Gy gamma-ray irradiated mice in 
the irradiation, irradiation + nilestriol (10 mg/kg), or irradiation + PQQ (2 mg/kg, 4 mg/kg, 
8 mg/kg) group. The respective groups comprised 20 mice. Statistical significance as 
compared to the irradiation group: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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If animals were divided by sex into two subgroups, survival of both male and female mice treated 
irradiation + PQQ (2 mg/kg, 4 mg/kg) was found to be still significantly higher in comparison with 
that of the mice treated with irradiation. It is the same to the mean surviving time of animals and the 
mean surviving time of dead animals, but the numerical value of male mice is lower than that of 
female mice (data not shown). It is accorded with the hypothesis that female may be more resistive 
against radiation than male because female could synthesize estrogen. 
2.3. Effect of PQQ on White Blood Cells 
Counting of blood cells in the blood of mice irradiated with a sublethal dose of 4.0 Gy revealed 
effects of the administration of nilestriol or PQQ on white blood cell. As shown in Table 1, mice 
exhibited a sharp decrease in peripheral white blood cell counts on days 3 after irradiation, and then 
recovered gradually up to days 21. In comparison with the irradiation group, the number of white 
blood cell were found to be significantly higher in the irradiation + nilestriol (10 mg/kg) group or 
irradiation + PQQ (4 mg/kg) group on days 12, 15, 18 and 21, while there was no significant difference 
in the numbers of white blood cell between irradiation + PQQ group and irradiation + nilestriol group. 
Like white blood cell, the blood erythrocytes, platelets and hemoglobin drop sharply after irradiation, 
and then recover gradually until day 21, but no significant differences were found by any comparison 
among three groups after irradiation (data not shown). 
Table 1. Effect of PQQ (4 mg/kg) on white blood cell in mice exposed to 4 Gy gamma 
irradiation (%). In comparison with the irradiation group, the number of white blood cell 
were found to be significantly higher in the irradiation + nilestriol group or irradiation + PQQ 
group on days 12, 15, 18 and 21, while there was no significant difference in the numbers 
of white blood cell between the latter two. Statistical significance as compared to the 
irradiation group: * p < 0.05, ** p < 0.01. 
Group 
Time of Irradiation (days) 
0 3 6 9 12  15  18  21 
Irradiation  1.00 ± 0.04  0.11 ± 0.04  0.26 ± 0.12 0.32 ± 0.13 0.42 ± 0.09  0.49 ± 0.12  0.55 ± 0.11  0.76 ± 0.22 
Irradiation + 
nilestriol 
1.00 ± 0.02  0.12 ± 0.04  0.19 ± 0.11 0.28 ± 0.14 0.54 ± 0.13 * 0.67 ± 0.22 *  0.70 ± 0.16 *  0.98 ± 0.32 *
Irradiation + 
PQQ 
1.00 ± 0.05  0.13 ± 0.04  0.19 ± 0.05 0.28 ± 0.09 0.54 ± 0.13 * 0.61 ± 0.08 *  0.74 ± 0.16 **  0.91 ± 0.16 *
2.4. Effect of PQQ on Reticulocytes 
Table 2 shows the effect of PQQ on reticulocytes. The percent change of reticulocyte was sharply 
increased on day 3 after irradiation then recovered gradually till day 21. The level of reticulocyte 
percentage was found to go back to normal on day 21 in the irradiation + nilestriol and irradiation + PQQ 
group. In comparison with the irradiation group, the percent change of reticulocyte was found to be 
significantly lower on days 9, 15, 21 in the irradiation + nilestriol and irradiation + PQQ group. Int. J. Mol. Sci. 2011, 12 8917 
 
 
Table 2. Effects of PQQ (4 mg/kg) on the percent change of reticulocytes (%) in mice 
exposed to 4 Gy gamma irradiation. In comparison with the irradiation group, the percent 
change of reticulocyte was found to be significantly lower on days 9, 15, 21 in the 
irradiation + nilestriol and irradiation + PQQ group. Statistical significance as compared to 
the irradiation group: * p < 0.05, ** p < 0.01. 
Group 
Time of Irradiation (days) 
0 3  9  15  21 
Irradiation  0.32 ± 0.16  4.62 ± 0.89 3.46 ± 0.66  1.63 ± 0.52  0.77 ± 0.43 
Irradiation + nilestriol 0.35 ± 0.21  4.55 ± 0.74 1.18 ± 0.61 * 0.94 ± 0.32 *  0.38 ± 0.18 *
Irradiation + PQQ  0.40 ± 0.29  4.07 ± 0.89 0.91 ± 0.33 ** 0.90 ± 0.32 *  0.41 ± 0.17 *
2.5. Effect of PQQ on Bone Marrow Cells 
Figure 2 shows that the number of bone marrow cells was significantly lower in the irradiation 
group ((1.200 ± 0.878) × 10
6 cells/femur) than that in irradiation + nilestriol group ((2.144 ± 1.052) × 
10
6 cells/femur, p < 0.05) and irradiation + PQQ group ((3.711 ± 1.691) × 10
6 cells/femur, p < 0.001) 
on day 21. There was also significant difference on the number of bone marrow cells in irradiation + PQQ 
group compared with that of the irradiation + nilestriol group (p < 0.05). 
Figure 2. Femoral bone marrow cells on day 21 after irradiation with 4.0 Gy in mice of the 
irradiation, irradiation + nilestriol and irradiation + PQQ groups. Statistical significance as 
compared to the irradiation group: * p < 0.05, *** p < 0.001. 
 
Acute effects of high-dose ionizing radiation include hematopoietic cell loss, immune suppression, 
mucosal damage (gastrointestinal and oral). Its main clinical symptoms depend on the magnitude of 
absorbed dose [21]. Generally, the death of the irradiated animals was largely attributed to hematopoietic 
syndrome with irradiation doses of 5–10 Gy, which is characterized by an impaired bone marrow 
hematopoietic function [22]. Our results show that the administration of PQQ reduced the mice’s 
radiation-induced mortality, and it apparently did so by protecting hematopoietic system from the effects 
of irradiation. In general, hematopoietic system (mainly bone marrow tissue and white blood cell) are 
highly radiosensitive, while erythrocytes, platelets and hemoglobin were less affected by radiation. As 
can be seen from the results, white blood cell as well as bone marrow cell was significantly protected 
with 4 mg/kg dose of PQQ against irradiation. Int. J. Mol. Sci. 2011, 12 8918 
 
 
In addition to the results discussed above, the effect of PQQ was compared with that of nilestriol in 
the present study. Nilestriol, a prolonged-action derivative of estriol, is thought to be a drug against 
radiation injury [23,24]. Its pharmacological role is to increase leucocyte counts and improve 
hematopoietic function after irradiation. As a representative of estrogenic radioprotector, nilestriol has 
been approved by SFDA (State Food and Drug Administration, China) for many years and used widely 
for antiradiation in clinical therapy. In many pharmacodynamic researches, it was taken as positive 
control drug [25,26]. In the present study, both nilestriol and PQQ significantly enhanced the recovery 
of leucocytes, reticulocytes and bone marrow cells in whole body irradiated mice. Moreover, survival 
of the irradiation + PQQ (4 mg/kg) group is higher than that of the irradiation + PQQ group (p < 0.05), 
and the numbers of bone marrow cells in the irradiation + PQQ group were significantly higher than 
that in the irradiation + nilestriol group (p < 0.05). 
The effects of PQQ on whole-body irradiated animals are not fully understood, but one possible 
mechanism involves its antioxidant properties. It is well known that ionizing radiation produce ROS, 
which are implicated in the process of DNA damage, cell killing, mutagenesis and carcinogenesis. 
Therefore, it is reasonable to presume that agents capable of scavenging free radicals would play  
a significant role in rescuing these processes. The radioprotection of normal cells by a number of 
synthetic and natural compounds has been reported to be mediated through free radical scavenging 
activity [27]. PQQ exhibited scavenging activity toward intracellular ROS [25]. The structural analysis 
of PQQ with other anti-oxidants such as indole and pyrrole derivatives, which act as ROS scavenger, 
showed that PQQ exhibits comparatively higher reactive electron density, making it a relatively strong 
antioxidant [28]. Using nanosecond pulse radiolysis technique, PQQ was shown to react with 
radiolytically produced reactive oxygen species, such as superoxide radicals and hydroxyl radicals  
in vitro [29]. In solution, PQQ protected plasmid DNA from nicking and proteins from oxidative 
damage caused by gamma-rays [29]. Research results also indicated that PQQ has a regulatory role in 
the resistance of Deinococcus radiodurans to oxidative stress from radiation and DNA-damaging 
agents [14]. Transgenic E. coli cells producing PQQ showed decreased levels of protein oxidation 
during oxidative stress [30]. These results suggest that PQQ acts as ROS scavenger by directly 
neutralizing the reactive species and protects the bacterial cells from oxidative stress. PQQ has been 
also indicated to protect oxidative stress-induced neuronal death [17] and prevent cognitive deficit 
caused by oxidative stress in mice [31] and scavenge free radicals in skin and serum of SD rats after 
linear accelerator radiation acute skin injury [16]. However, the molecular and cellular mechanism for 
the radioprotective effects of PQQ remains to be determined. 
3. Experimental Section 
3.1. Bacteria and Chemicals 
The Methylovorus sp. MP688 strain (CGMCC No. 4096) was isolated from soil by our lab as a 
PQQ producer. The MM medium contained the following components: MgSO4·7H2O 0.2 g/L, 
(NH4)2SO4 3.0 g/L, KH2PO4 1.4 g/L, Na2HPO4·12H2O 3.0 g/L, C6H5O7Fe·5H2O 30 mg/L, 
MnCl2·4H2O 5.0 mg/L, CaCl2·2H2O 30 mg/L, ZnSO4·7H2O 5.0 mg/L, CuSO4·5H2O 0.5 mg/L, CH3OH 
1% (v/v). The DEAE Sepharose F.F. column used was obtained from GE Inc. The C18 reverse-phase Int. J. Mol. Sci. 2011, 12 8919 
 
 
column was purchased from Dalian institute of chemical physics, Chinese academy of sciences. PQQ 
standard was purchased from Sigma Chemical Corporation and stock solutions were prepared in water. 
Nilestriol was bought from Shanghai New Hualian pharmaceutical Co., Ltd. (State medical permit  
No. H31021647). All other chemicals used were of analytical reagent grade quality or better and were 
obtained from the usual commercial sources. 
3.2. Batch Cultivation of MP688 in a 3-L Bioreactor 
Batch fermentation of the Methylovorus sp. MP688 was performed in a 3 L fermentor (BioStat B5, 
B. Braun Biotech International, Melsungen, Germany). Seed culture for bioreactor was started from 
fresh colony that grew on MM plate and was inoculated directly into 500 mL flasks (100 mL working 
volume) containing MM medium. After 72 h of growth (30 °C, 200 rpm), seed culture was used to 
inoculate into the bioreactor. 100 mL inoculum (4% v/v) was used for the inoculation of 3 L bioreactor 
containing 2.5 L medium. Dissolved oxygen was maintained at over 85% air saturation and culture 
temperature was controlled at 30 °C with pH set at 5.8. The fermentation process was terminated when 
PQQ stopped accumulating in the culture supernatant. 
3.3. PQQ Purification 
The medium was applied to a DEAE Sepharose F.F. anion-exchange column at a flow rate of  
1 mL/min after centrifugation for 30 min at 2500 g, 4 °C. The column was equilibrated with 20 mM 
sodium citrate buffer, pH 5.5. PQQ was eluted from the column using 20 mM sodium citrate buffer, 
1.0 M NaCl, pH 5.5. The fractions containing PQQ were pooled to one fourth volume for further 
purification by rotary evaporation. The pooled solution was crystallized at 4 °C overnight and the 
collected crystalline was further recrystallized. The final crystalline was dissolved with a 0.1 M 
potassium phosphate buffer (pH 7.0) and saved for HPLC analysis. 
3.4. PQQ Analysis 
Samples of PQQ (20 μL) or standard PQQ solution were injected onto the reverse-phase C18 
column and eluted at a flow rate of 1.0 mL/min with a 70:30 mixture of H2O/MeOH (v/v). The   
high-pressure liquid chromatography analyses were performed with a Waters
TM 600 pump and   
a Waters 600 controller. Eluted PQQ was detected with a Waters 2996 photodiode array detector  
with detection wavelength of 254 nm. Absorption spectra were measured on a Unico UV2102 
spectrophotometer with samples of 2 mm light path. 
3.5. Animals 
KM strain mice with weight of 16–18 g were purchased from the Animal Center, Academy of 
Military Medical Sciences. These mice were selected and divided into different groups (20 mice per 
group), namely, irradiation, irradiation + PQQ, irradiation+nilestriol groups, and ten mice were housed 
in each cage. All animals were kept under controlled lighting conditions (light/dark 12 h/12 h) at  
a temperature of 25 ± 1 °C and relative humidity of 40%–70%. Int. J. Mol. Sci. 2011, 12 8920 
 
 
3.6. Irradiation 
All mice were irradiated with single whole body doses using a 
60Co gamma-ray source (Institute of 
radiation medicine, Academy of Military Medical Sciences) at a dose rate of 236.05 cGy/min. The 
mice were placed in ventilated cages and groups of ten mice were irradiated simultaneously. The mice 
were irradiated with a total dose of 8 Gy gamma-rays in survival test and 4 Gy gamma-rays in 
haemopoiesis test. 
3.7. Administration 
Nilestriol and PQQ were dissolved in saline and taken orally by mice for all experiments. In 
survival test, for the selection of the optimum dose of PQQ for radioprotection, three doses (2 mg/kg,  
4 mg/kg, 8 mg/kg) of PQQ were administrated to the experimental animals 1 h before gamma 
irradiation and once daily for 7 consecutive days after gamma irradiation. The control animals received 
the same volume of saline or nilestriol (10 mg/kg) at 1 h before gamma irradiation and 1 day after 
gamma irradiation. Twenty mice were used for each treatment group, female and male evenly. In 
haemopoiesis test, mice were divided into 3 equal groups: PQQ 4 mg/kg, nilestriol 10 mg/kg and 
control. The administration of drug is the same as that in survival test. 
3.8. Survival 
In experiments evaluating the morality of animals, the survival time was recorded in daily intervals 
for 30 days after lethal irradiation. 
3.9. Haematological Methods 
In experiments evaluating hematocytes, blood samples were collected from the tail vein on days 0, 
3, 6, 9, 12, 15, 18, 21 after sublethal irradiation. At each harvest time, samples were taken from ten 
mice per group, and the results were averaged over these ten animals. The other ten mice were handled 
at the next harvest time. The fluctuation of hemograms was automatically counted by a hematocyte 
counter (Sysmex F820 hematology analyser, Sysmex, Milton, UK) on all days of sampling. Mice were 
killed by cervical dislocation on days 21, and their femurs were dissected. Bone marrow cells were 
flushed with PBS and counted using a hematocytometer. The results are expressed as the number of 
live bone marrow cells (10
6)/femur. 
3.10. Statistic Analysis 
The data were expressed as mean ± standard error. Statistical analyses of numeration data   
were performed using analysis of χ
2 text, while Statistical analyses of measurement data were 
performed using analysis of Student’s t-test. Survival data were analyzed by life-table method using 
the Kaplan-Meier method. The significance level was set at p < 0.05. Int. J. Mol. Sci. 2011, 12 8921 
 
 
4. Conclusions 
In this study, we reported the production and extraction of PQQ. The results showed that the highest 
yield of PQQ reached 125 mg/L at day 6, and it was efficiently extracted by chromatography, 
crystallization and recrystallization. Animal test suggested that PQQ exerted significant protection to 
mice against irradiation injury and this effect was associated with the recovery of hematopoietic function. 
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